Kathryn Arrambide, M.D., F.A.C.P.
Kevin Tulipana, D.O.


Tulsa, Okla. – Cancer Treatment Centers of America® at Southwestern Regional Medical Center in Tulsa (CTCA) announces two recent physician changes – Kathryn Arrambide, M.D., F.A.C.P., has joined the hospital as a medical oncologist and hematologist and Kevin Tulipana, D.O., who served as a hospitalist in the special care unit, has been promoted to medical director of hospital medicine.
Dr. Arrambide has extensive experience in treating blood cancers and disorders, as well as lung, breast, cervical, uterine and advanced-staged cancers. In addition, she is board certified in medical oncology and hematology. Prior to joining CTCA®, Dr. Arrambide worked at a medical group in Quincy, Ill., where she was a partner and served as medical director of clinical research. Prior to that, she practiced at various clinics and hospitals in the Dallas area, where she grew up.
With a bachelor of science degree in clinical nutrition with an emphasis in nutrition in cancer patients from the University of Texas Health Science Center at Dallas, Dr. Arrambide received her doctor of medicine at the University of Texas Southwestern Medical Center and later completed her hematology/oncology fellowship there. She also served as chief fellow in hematology/medical oncology from 1994 to 1995.
Dr. Tulipana, who joined CTCA in January 2015, earned his bachelor’s degree in biology at Truman State University in Kirksville, Mo. He completed his doctor of osteopathy degree at Des Moines University College of Osteopathic Medicine & Surgery. He was a resident in Family Medicine at Mercy/Mayo Family Medical Center, serving as chief resident from 2002 to 2003.
Prior to joining CTCA, Dr. Tulipana provided family medical care at a large regional medical center in Missouri for seven years. He then served as hospitalist at a large health-care facility in Oklahoma. During his career, Dr. Tulipana has also held several administrative positions focused on quality improvement, innovation and other aspects of patient care.
“We are thrilled about Dr. Arrambide joining our team. Her background aligns strongly with the CTCA model of care, and she has a good grasp on the whole-person needs of cancer patients,” said Dr. Daniel Nader, chief of staff at the Tulsa hospital. “We are also excited about Dr. Tulipana’s promotion. He understands the importance of compassionate care, while also being committed to quality improvement and innovation.”